 | • レポートコード：D005-06023 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、内分泌系薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。内分泌系薬の種類別市場規模（糖尿病薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他）、用途別市場規模（病院、クリニック、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novo Nordisk、Eli Lilly、Sanofi、Merck、AbbVie、AstraZeneca ・地域別グローバル市場分析 2015年-2020年 ・内分泌系薬の北米市場（アメリカ、カナダ、メキシコ） ・内分泌系薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・内分泌系薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・内分泌系薬の南米市場（ブラジル、アルゼンチン） ・内分泌系薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：糖尿病薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他 ・用途別分析：病院、クリニック、医療センター、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Endocrine System Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Endocrine System Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Endocrine System Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Endocrine System Drug market has been segmented into
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others
By Application, Endocrine System Drug has been segmented into:
Hospital
Clinic
Medical Center
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Endocrine System Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Endocrine System Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Endocrine System Drug market.
The report offers in-depth assessment of the growth and other aspects of the Endocrine System Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Endocrine System Drug Market Share Analysis
Endocrine System Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Endocrine System Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Endocrine System Drug sales, revenue and market share for each player covered in this report.
The major players covered in Endocrine System Drug are:
Novo Nordisk
Eli Lilly
Sanofi
Merck
AbbVie
AstraZeneca
Among other players domestic and global, Endocrine System Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endocrine System Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Endocrine System Drug, with price, sales, revenue and global market share of Endocrine System Drug in 2018 and 2019.
Chapter 3, the Endocrine System Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endocrine System Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Endocrine System Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Endocrine System Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Endocrine System Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Endocrine System Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Diabetes Drug
1.2.3 Human Growth Hormones
1.2.4 Thyroid Hormone Disorder Drugs
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Endocrine System Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Overview of Global Endocrine System Drug Market
1.4.1 Global Endocrine System Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Endocrine System Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Endocrine System Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Endocrine System Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Endocrine System Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Endocrine System Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Endocrine System Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Endocrine System Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Endocrine System Drug Sales and Growth Rate (2015-2020)
4.3 Europe Endocrine System Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Endocrine System Drug Sales and Growth Rate (2015-2020)
4.5 South America Endocrine System Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Endocrine System Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Endocrine System Drug Sales, Revenue and Market Share by Country
5.1.1 North America Endocrine System Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Endocrine System Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Endocrine System Drug Sales and Growth Rate (2015-2020)
5.3 Canada Endocrine System Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Endocrine System Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Endocrine System Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Endocrine System Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Endocrine System Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Endocrine System Drug Sales and Growth Rate (2015-2020)
6.3 UK Endocrine System Drug Sales and Growth Rate (2015-2020)
6.4 France Endocrine System Drug Sales and Growth Rate (2015-2020)
6.5 Russia Endocrine System Drug Sales and Growth Rate (2015-2020)
6.6 Italy Endocrine System Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Endocrine System Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Endocrine System Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Endocrine System Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Endocrine System Drug Sales and Growth Rate (2015-2020)
7.3 Japan Endocrine System Drug Sales and Growth Rate (2015-2020)
7.4 Korea Endocrine System Drug Sales and Growth Rate (2015-2020)
7.5 India Endocrine System Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Endocrine System Drug Sales and Growth Rate (2015-2020)
7.7 Australia Endocrine System Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Endocrine System Drug Sales, Revenue and Market Share by Country
8.1.1 South America Endocrine System Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Endocrine System Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Endocrine System Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Endocrine System Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Endocrine System Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Endocrine System Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Endocrine System Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Endocrine System Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Endocrine System Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Endocrine System Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Endocrine System Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Endocrine System Drug Sales and Market Share by Type (2015-2020)
10.2 Global Endocrine System Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Endocrine System Drug Price by Type (2015-2020)
11 Global Endocrine System Drug Market Segment by Application
11.1 Global Endocrine System Drug Sales Market Share by Application (2015-2020)
11.2 Global Endocrine System Drug Revenue Market Share by Application (2015-2020)
11.3 Global Endocrine System Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Endocrine System Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Endocrine System Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Endocrine System Drug Market Forecast (2021-2025)
12.2.2 Europe Endocrine System Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Endocrine System Drug Market Forecast (2021-2025)
12.2.4 South America Endocrine System Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Endocrine System Drug Market Forecast (2021-2025)
12.3 Endocrine System Drug Market Forecast by Type (2021-2025)
12.3.1 Global Endocrine System Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Endocrine System Drug Market Share Forecast by Type (2021-2025)
12.4 Endocrine System Drug Market Forecast by Application (2021-2025)
12.4.1 Global Endocrine System Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Endocrine System Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Endocrine System Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Endocrine System Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Endocrine System Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Endocrine System Drug Major Business
Table 9. Novo Nordisk Endocrine System Drug Total Revenue (USD Million) (2018-2019)
Table 10. Novo Nordisk SWOT Analysis
Table 11. Novo Nordisk Endocrine System Drug Product and Services
Table 12. Novo Nordisk Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Endocrine System Drug Major Business
Table 15. Eli Lilly Endocrine System Drug Total Revenue (USD Million) (2018-2019)
Table 16. Eli Lilly SWOT Analysis
Table 17. Eli Lilly Endocrine System Drug Product and Services
Table 18. Eli Lilly Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Endocrine System Drug Major Business
Table 21. Sanofi Endocrine System Drug Total Revenue (USD Million) (2018-2019)
Table 22. Sanofi SWOT Analysis
Table 23. Sanofi Endocrine System Drug Product and Services
Table 24. Sanofi Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck Endocrine System Drug Major Business
Table 27. Merck Endocrine System Drug Total Revenue (USD Million) (2018-2019)
Table 28. Merck SWOT Analysis
Table 29. Merck Endocrine System Drug Product and Services
Table 30. Merck Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Endocrine System Drug Major Business
Table 33. AbbVie Endocrine System Drug Total Revenue (USD Million) (2018-2019)
Table 34. AbbVie SWOT Analysis
Table 35. AbbVie Endocrine System Drug Product and Services
Table 36. AbbVie Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 38. AstraZeneca Endocrine System Drug Major Business
Table 39. AstraZeneca Endocrine System Drug Total Revenue (USD Million) (2018-2019)
Table 40. AstraZeneca SWOT Analysis
Table 41. AstraZeneca Endocrine System Drug Product and Services
Table 42. AstraZeneca Endocrine System Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Endocrine System Drug Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global Endocrine System Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Endocrine System Drug Sales by Regions (2015-2020) (K Units)
Table 46. Global Endocrine System Drug Sales Market Share by Regions (2015-2020)
Table 47. Global Endocrine System Drug Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Endocrine System Drug Sales by Countries (2015-2020) (K Units)
Table 49. North America Endocrine System Drug Sales Market Share by Countries (2015-2020)
Table 50. North America Endocrine System Drug Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Endocrine System Drug Revenue Market Share by Countries (2015-2020)
Table 52. Europe Endocrine System Drug Sales by Countries (2015-2020) (K Units)
Table 53. Europe Endocrine System Drug Sales Market Share by Countries (2015-2020)
Table 54. Europe Endocrine System Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Endocrine System Drug Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific Endocrine System Drug Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Endocrine System Drug Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Endocrine System Drug Sales by Countries (2015-2020) (K Units)
Table 59. South America Endocrine System Drug Sales Market Share by Countries (2015-2020)
Table 60. South America Endocrine System Drug Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Endocrine System Drug Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Endocrine System Drug Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa Endocrine System Drug Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Endocrine System Drug Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Endocrine System Drug Revenue Market Share by Countries (2015-2020)
Table 66. Global Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 67. Global Endocrine System Drug Sales Share by Type (2015-2020)
Table 68. Global Endocrine System Drug Revenue by Type (2015-2020) (USD Million)
Table 69. Global Endocrine System Drug Revenue Share by Type (2015-2020)
Table 70. Global Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 71. Global Endocrine System Drug Sales Share by Application (2015-2020)
Table 72. Global Endocrine System Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global Endocrine System Drug Market Share Forecast by Regions (2021-2025)
Table 74. Global Endocrine System Drug Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global Endocrine System Drug Market Share Forecast by Type (2021-2025)
Table 76. Global Endocrine System Drug Sales Forecast by Application (2021-2025)
Table 77. Global Endocrine System Drug Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Endocrine System Drug Picture
Figure 2. Global Sales Market Share of Endocrine System Drug by Type in 2019
Figure 3. Diabetes Drug Picture
Figure 4. Human Growth Hormones Picture
Figure 5. Thyroid Hormone Disorder Drugs Picture
Figure 6. Others Picture
Figure 7. Endocrine System Drug Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Medical Center Picture
Figure 11. Others Picture
Figure 12. Global Endocrine System Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Endocrine System Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Endocrine System Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Endocrine System Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Endocrine System Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Endocrine System Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Endocrine System Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Endocrine System Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Endocrine System Drug Revenue Market Share by Regions in 2018
Figure 41. North America Endocrine System Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Endocrine System Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Endocrine System Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Endocrine System Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Endocrine System Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Endocrine System Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Endocrine System Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Endocrine System Drug Sales Market Share by Countries in 2018
Figure 49. North America Endocrine System Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Endocrine System Drug Revenue Market Share by Countries in 2018
Figure 51. United States Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Endocrine System Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Endocrine System Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Endocrine System Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Endocrine System Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Endocrine System Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Endocrine System Drug Revenue Market Share by Regions 2019
Figure 65. China Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Endocrine System Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Endocrine System Drug Sales Market Share by Countries in 2019
Figure 72. South America Endocrine System Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Endocrine System Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Endocrine System Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Endocrine System Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Endocrine System Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Endocrine System Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Endocrine System Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Endocrine System Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Endocrine System Drug Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Endocrine System Drug Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Endocrine System Drug Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Endocrine System Drug Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Endocrine System Drug Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
消化器系薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Digestive System Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Digestive System Drug m…- 注意欠陥多動性障害（ADHD）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…
- アレルギー鼻炎薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Allergy Rhinitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergy Rhinitis Drug m…
- 薬物キャビネットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug Cabinets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug Cabinets market report pro…
- 胃食道逆流症（GERD）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gastro Esophageal Reflux Disease (GERD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …